Litcius/Paper detail

The U.S. FDA approved cardiovascular drugs from 2011 to 2023: A medicinal chemistry perspective

Yunhan Jiang, Pingxian Liu, Zhiqiang Qiu, Meng Zhou, Mengdi Cheng, Tao Yang

2024European Journal of Medicinal Chemistry10 citationsDOIOpen Access PDF

Topics & Concepts

PharmacologyDrug developmentDrugDrug discoveryChemistryDiseaseMedicineIntensive care medicineInternal medicineBiochemistrySynthesis and Biological EvaluationMetal complexes synthesis and propertiesClick Chemistry and Applications
The U.S. FDA approved cardiovascular drugs from 2011 to 2023: A medicinal chemistry perspective | Litcius